Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$3.76 - $5.14 $184,461 - $252,163
-49,059 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$4.81 - $8.74 $9,812 - $17,829
-2,040 Reduced 3.99%
49,059 $248,000
Q4 2020

Feb 10, 2021

BUY
$5.03 - $6.31 $15,844 - $19,876
3,150 Added 6.57%
51,099 $269,000
Q3 2020

Nov 12, 2020

SELL
$4.67 - $11.0 $33,880 - $79,805
-7,255 Reduced 13.14%
47,949 $251,000
Q2 2020

Aug 13, 2020

BUY
$3.06 - $7.06 $6,762 - $15,602
2,210 Added 4.17%
55,204 $299,000
Q4 2019

Feb 05, 2020

BUY
$6.48 - $8.76 $1,814 - $2,452
280 Added 0.53%
52,994 $357,000
Q3 2019

Oct 23, 2019

SELL
$7.7 - $10.42 $3,080 - $4,168
-400 Reduced 0.75%
52,714 $419,000
Q2 2019

Aug 14, 2019

BUY
$8.29 - $13.22 $13,147 - $20,966
1,586 Added 3.08%
53,114 $511,000
Q1 2019

May 01, 2019

SELL
$6.82 - $10.27 $9,207 - $13,864
-1,350 Reduced 2.55%
51,528 $427,000
Q4 2018

Jan 31, 2019

BUY
$7.65 - $12.83 $132,230 - $221,766
17,285 Added 48.56%
52,878 $432,000
Q3 2018

Nov 07, 2018

SELL
$7.06 - $12.49 $16,591 - $29,351
-2,350 Reduced 6.19%
35,593 $445,000
Q2 2018

Aug 06, 2018

BUY
$7.96 - $13.23 $41,017 - $68,174
5,153 Added 15.72%
37,943 $302,000
Q1 2018

May 02, 2018

BUY
$6.6 - $13.91 $18,282 - $38,530
2,770 Added 9.23%
32,790 $335,000
Q4 2017

Feb 09, 2018

SELL
$5.89 - $7.21 $41,424 - $50,707
-7,033 Reduced 18.98%
30,020 $194,000
Q3 2017

Nov 06, 2017

BUY
$4.43 - $6.58 $164,144 - $243,808
37,053
37,053 $236,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.